Skip to content

A prospective, randomized controlled clinical trial of prostate biopsy guided by prostate puncture positioning system

A prospective, randomized controlled clinical trial of prostate biopsy guided by prostate puncture positioning system

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200056987
Enrollment
Unknown
Registered
2022-02-25
Start date
2022-02-20
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostatic cancer

Interventions

Experimental group:Use prostate positioning puncture system
Control group:Traditional ultrasound-guided prostate puncturere

Sponsors

Gulou Hospital Affiliated to Medical College of Nanjing University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
No minimum to 80 Years

Inclusion criteria

Inclusion criteria: 1. Male, age = 10 µg/L (3) 4 µg/L = 3; 4. Sign written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with confirmed prostate cancer or acute prostatitis; 2. Acute infection of urogenital system; 3. Prostate puncture within 1 month; 4. In the decompensated stage of cardiac insufficiency (NYHA cardiac function grade III or IV); 5. Patients with severe bleeding tendency, or those who cannot stop taking anticoagulants for a long time; 6. Severe internal hemorrhoids, external hemorrhoids, perianal or rectal lesions; 7. Patients with severe bone and joint diseases who cannot be placed in the left lying position or lithotomy position; 8. Hypertension crisis; 9. Suffering from mental illness or mental disorder and unable to understand the informed consent form; 10. Other surgical contraindications, or those who are considered unsuitable by the investigator to participate in the trial.

Design outcomes

Primary

MeasureTime frame
Positive detection rate of prostate cancer;

Countries

China

Contacts

Public ContactDing Xuefei

Northern Jiangsu People's Hospital

xuefeid@126.com+86 18051061234

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026